Harlan F. Weisman - Jul 3, 2024 Form 4 Insider Report for TFF Pharmaceuticals, Inc. (TFFP)

Role
President and CEO, Director
Signature
/s/ Harlan F. Weisman, by Kirk Allen Coleman, as Attorney-in-Fact
Stock symbol
TFFP
Transactions as of
Jul 3, 2024
Transactions value $
$0
Form type
4
Date filed
7/8/2024, 05:46 PM
Previous filing
Apr 22, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TFFP Common Stock Award $0 +27.5K +3.37% $0.00 842K Jul 3, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TFFP Stock Options (Right to Buy) Award $0 +27.5K $0.00 27.5K Jul 3, 2024 Common Stock 27.5K $1.82 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock underlying restricted stock units ("RSUs"). Each RSU entitles its holder to receive one share of common stock of the issuer. The RSUs vest and settle in sixteen equal quarterly installments with a one-year cliff.
F2 One-quarter of the options vest and first become exercisable on June 19, 2025 and the remainder of the options vest and first become exercisable in 12 equal quarterly installments commencing on September 19, 2025.